AGP Executive Report
Last update: 9 hours agoHepatitis B Vaccines: Guinea-Bissau has cancelled a proposed U.S.-funded trial involving 14,000 newborns after ethical concerns over delaying the birth-dose vaccine for half the babies until six weeks of age. The WHO recommends vaccination at birth to protect infants from hepatitis B, which can cause lifelong infection and serious liver disease. The government said it had not authorised the study, and police seized vaccine supplies from the research centre.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.